Annual Gross Profit
$41.39 M
+$8.31 M+25.12%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual gross profit is currently $41.39 million, with the most recent change of +$8.31 million (+25.12%) on 31 December 2023. During the last 3 years, it has risen by +$12.77 million (+44.64%). EYPT annual gross profit is now at all-time high.EYPT Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$9.79 M
+$1.71 M+21.20%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly gross profit is currently $9.79 million, with the most recent change of +$1.71 million (+21.20%) on 30 September 2024. Over the past year, it has dropped by -$4.21 million (-30.09%). EYPT quarterly gross profit is now -37.74% below its all-time high of $15.72 million, reached on 30 June 2010.EYPT Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$41.82 M
-$4.21 M-9.15%
30 September 2024
Summary:
EyePoint Pharmaceuticals TTM gross profit is currently $41.82 million, with the most recent change of -$4.21 million (-9.15%) on 30 September 2024. Over the past year, it has increased by +$6.34 million (+17.87%). EYPT TTM gross profit is now -9.15% below its all-time high of $46.03 million, reached on 30 June 2024.EYPT TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.1% | -30.1% | +17.9% |
| 3 y3 years | +44.6% | +35.3% | +67.8% |
| 5 y5 years | +1313.5% | +348.6% | +303.4% |
EYPT Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +44.6% | -30.1% | +39.0% | -9.2% | +67.8% |
| 5 y | 5 years | at high | +1313.5% | -30.1% | +348.6% | -9.2% | +303.4% |
| alltime | all time | at high | +1313.5% | -37.7% | +390.6% | -9.2% | +1341.7% |
EyePoint Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.79 M(+21.2%) | $41.82 M(-9.2%) |
| June 2024 | - | $8.08 M(-26.1%) | $46.03 M(+1.7%) |
| Mar 2024 | - | $10.93 M(-16.2%) | $45.27 M(+9.4%) |
| Dec 2023 | $41.39 M(+25.1%) | $13.03 M(-6.9%) | $41.39 M(+16.6%) |
| Sept 2023 | - | $14.00 M(+91.4%) | $35.48 M(+17.9%) |
| June 2023 | - | $7.31 M(+3.8%) | $30.09 M(-7.7%) |
| Mar 2023 | - | $7.04 M(-1.1%) | $32.60 M(-1.4%) |
| Dec 2022 | $33.08 M(+15.0%) | $7.12 M(-17.2%) | $33.08 M(-4.0%) |
| Sept 2022 | - | $8.61 M(-12.5%) | $34.47 M(+4.1%) |
| June 2022 | - | $9.83 M(+30.8%) | $33.09 M(+9.1%) |
| Mar 2022 | - | $7.52 M(-11.7%) | $30.35 M(+5.5%) |
| Dec 2021 | $28.76 M(+0.5%) | $8.51 M(+17.7%) | $28.76 M(+15.4%) |
| Sept 2021 | - | $7.23 M(+2.1%) | $24.92 M(-20.9%) |
| June 2021 | - | $7.08 M(+19.4%) | $31.50 M(+12.4%) |
| Mar 2021 | - | $5.93 M(+27.0%) | $28.04 M(-2.0%) |
| Dec 2020 | $28.61 M(+61.9%) | $4.67 M(-66.2%) | $28.61 M(-8.4%) |
| Sept 2020 | - | $13.81 M(+281.6%) | $31.25 M(+59.3%) |
| June 2020 | - | $3.62 M(-44.4%) | $19.62 M(-12.8%) |
| Mar 2020 | - | $6.51 M(-10.9%) | $22.50 M(+27.3%) |
| Dec 2019 | $17.68 M | $7.31 M(+235.0%) | $17.68 M(+70.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $2.18 M(-66.5%) | $10.37 M(+26.7%) |
| June 2019 | - | $6.50 M(+286.7%) | $8.19 M(+386.7%) |
| Mar 2019 | - | $1.68 M(+1.4%) | $1.68 M(-30.9%) |
| Dec 2018 | $2.93 M(-1.1%) | - | - |
| June 2018 | $2.96 M(-60.7%) | - | - |
| June 2017 | $7.54 M(-67.3%) | - | - |
| Sept 2011 | - | $1.66 M(+360.8%) | $2.43 M(-85.7%) |
| Mar 2011 | - | $360.00 K(-13.0%) | $16.97 M(-0.9%) |
| Dec 2010 | - | $414.00 K(-13.0%) | $17.13 M(-15.0%) |
| Sept 2010 | - | $476.00 K(-97.0%) | $20.15 M(-12.6%) |
| June 2010 | $23.05 M(+89.5%) | $15.72 M(+2952.8%) | $23.05 M(+118.4%) |
| Mar 2010 | - | $515.00 K(-85.0%) | $10.55 M(-20.1%) |
| Dec 2009 | - | $3.43 M(+1.5%) | $13.20 M(+3.6%) |
| Sept 2009 | - | $3.38 M(+5.0%) | $12.74 M(+28.2%) |
| June 2009 | $12.16 M(+249.9%) | $3.22 M(+1.9%) | $9.93 M(+48.0%) |
| Mar 2009 | - | $3.16 M(+6.5%) | $6.71 M(+89.1%) |
| Dec 2008 | - | $2.97 M(+413.8%) | $3.55 M(+513.8%) |
| Sept 2008 | - | $578.00 K(-117.2%) | $578.00 K(-117.2%) |
| June 2008 | $3.48 M | - | - |
| Sept 2007 | - | -$3.37 M | -$3.37 M |
FAQ
- What is EyePoint Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual gross profit year-on-year change?
- What is EyePoint Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly gross profit year-on-year change?
- What is EyePoint Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals TTM gross profit year-on-year change?
What is EyePoint Pharmaceuticals annual gross profit?
The current annual gross profit of EYPT is $41.39 M
What is the all time high annual gross profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual gross profit is $41.39 M
What is EyePoint Pharmaceuticals annual gross profit year-on-year change?
Over the past year, EYPT annual gross profit has changed by +$8.31 M (+25.12%)
What is EyePoint Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of EYPT is $9.79 M
What is the all time high quarterly gross profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly gross profit is $15.72 M
What is EyePoint Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, EYPT quarterly gross profit has changed by -$4.21 M (-30.09%)
What is EyePoint Pharmaceuticals TTM gross profit?
The current TTM gross profit of EYPT is $41.82 M
What is the all time high TTM gross profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high TTM gross profit is $46.03 M
What is EyePoint Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, EYPT TTM gross profit has changed by +$6.34 M (+17.87%)